How should we monitor if we combine treatments
Clinical trials consistently show approximately 12-15% body weight reduction with Ozempic versus 2-5% with metformin
July 17, 2025: EU Clears Ozempic for Heart Conditions, Even Though Reports of Side Effects Are Rising Drug regulators in the European Union have given doctors the all-clear to prescribe Ozempic to treat peripheral artery disease, a type of heart condition
Real-world comparative effectiveness studies have corroborated clinical trial findings
Importantly, TRICARE For Life (TFL) does not cover weight loss medications, including popular GLP-1 drugs such as Wegovy, Zepbound, Saxenda, Qsymia, Phentermine, and Contrave, when prescribed for weight loss purposes
2 Methods PubMed was the primary database searched for this review